Dette skyldtes navnlig, at der var flere patienter, der afbrød behandlingen med Invirase, og ikke forskelle i selve lægemidlernes virkning.
This was mainly caused by more patients stopping Invirase treatment rather than by any differences in the effectiveness of the medicines.